Contract notice: Pharmaceutical products

• Country: Germany
• Summary: Contract notice: Pharmaceutical products
• DET Ref No: 32073022
• Deadline: 31 May 2021
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 159044-2019
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Object of the contract
  Pharmaceutical products
  
  Description: Contract notice: Pharmaceutical products
  
  Authority Type: Body governed by public law
  Contact Nature: Supplies
  Procedure: Open procedure
  Document: Contract notice
  Regulation: European Union, with participation by GPA countries
  Award criteria: Lowest price
  CPV code: 33600000,33600000
  CPV Description: Pharmaceutical products.
  Non-exclusive drug discount agreements according to - 130a Abs. 8 SGB V with possibility to conclude the drug darunavir (ATC-Code according to WHO: J05AE10)
  Reference Number: 78/2019-OH
  The subject matter of this publication is the conclusion of Non-exclusive discount agreements according to - 130a Abs. 8 SGB V for drugs to the drug Darunavir (ATC code accWHO: J05AE10) as part of an "open-house model." All interested and suitable pharmaceutical companies are offered a discount agreement in accordance with - 130a Para. 8 SGB V, subject to uniform conditions and a uniform access procedure The purchase quantity is unknown upon conclusion of the agreement and espOthers depend on the demand of insured persons, the development of the number of insured persons, the prescription behavior of the contracted doctors and the dispensing and stocking behavior of the public pharmacies. The client does not guarantee minimum purchase quantities.
  Main Site: Federal Republic of Germany
  The agreement can be concluded at any time and on the same conditions.Individual contract negotiations will not be carried out.
  Interested pharmaceutical companies may request the participation documents (discount agreement and the form mentioned under III.1.1) via the e-mail address mentioned under I.1).
  Agreements under this model will be made in the period from 25.4.2019 to 31.5.2021 closed. Interested parties have completely ausgefueFor the first time until 24.4.2019, and then before the 15th of each month, the participation documents (self-declaration on the absence of exclusion grounds and discount agreement) must be submitted to the office mentioned under I.1). It depends on the access at the AOK PLUS. If the 15th of a month falls on a Saturday, Sunday or nationwide public holiday, it will come to the placesuch day the next working day. In the event of late arrival (after 24.4.2019 or 15th of each month), the participation documents submitted will be taken into account on the 15th of the following month.
  The discount agreement will come into effect upon signing the AOK PLUS. The signing on the first submission until 24.4.2019 will take place up to and including the 18th calendar week 2019. NachThe discount agreements submitted on April 24, 2019 will be signed by the AOK PLUS by the end of the month in which the registration documents have to be received by the AOK PLUS.
  Organizationally, AOK PLUS will require a lead time of approx To make announcements of the discount agreement. The initial identification of discount medicines in pharmaciesoftware takes place from the second month following the submission deadline. In the case of changes or new specifications of the deadlines for the deadline declarations in the nationwide AOK contract reporting portal DatRabatt, this date may vary. With all pharmaceutical companies that meet the eligibility requirements by signing the requested sub-itemA contract is concluded at the latest on 31.5.2021, regardless of the date of conclusion of the contract. AOK PLUS reserves the right to terminate the open-house procedure prematurely, especially in the case of the conclusion of exclusive discount agreements. In this case, the contracts already concluded shall terminate in accordance with the contractual provisionsIn the experience of AOK PLUS, exclusive rebate agreements will normally enter into force 8 to 12 months after the publication of the relevant call for tenders in the Supplement to the Official Journal of the European Union. The future contractors in the open-house model are invited to do so regularly in the Supplement to the Official Journal of the European Union
  Note: this publication does not constitute a public contract within the meaning of the Public Procurement Directive (2014/24 / EU) or public procurement law. In order to ensure the widest possible degree of transparency for the intended conclusion of the contract, it will be published in the Supplement to the Official Journal of the European Union. In the absence eThe contract notice will be used in the corresponding publication form. The resulting requirements ("mandatory fields"), such as the procedure name "open procedure", "award criteria" and "conditions for the opening of bids" are solely due to the use of this announcement form and the publication platform. Another meaning inin particular a submission to public procurement regulations, unless they are legally binding, is not connected with this.
  - Self-declaration on the absence of grounds for exclusion.
  This notice does not concern the award of a public service contract within the meaning of the Public Procurement Directive (2014/24 / EU ) or public procurement law. The information in section VI.4)In the alternative, they do not justify submission to public procurement regulations whose validity is not prescribed by law or public procurement regulations
  Internet address (URL): https://plus.aok.de
• Documents:

 Tender Notice